Aberrant sorting of hippocampal complex pyramidal cells in type I lissencephaly alters topological innervation.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
19 06 2020
Historique:
received: 15 01 2020
accepted: 19 06 2020
pubmed: 20 6 2020
medline: 17 2 2021
entrez: 20 6 2020
Statut: epublish

Résumé

Layering has been a long-appreciated feature of higher order mammalian brain structures but the extent to which it plays an instructive role in synaptic specification remains unknown. Here we examine the formation of synaptic circuitry under cellular heterotopia in hippocampal CA1, using a mouse model of the human neurodevelopmental disorder Type I Lissencephaly. We identify calbindin-expressing principal cells which are mispositioned under cellular heterotopia. Ectopic calbindin-expressing principal cells develop relatively normal morphological features and stunted intrinsic physiological features. Regarding network development, a connectivity preference for cholecystokinin-expressing interneurons to target calbindin-expressing principal cells is diminished. Moreover, in vitro gamma oscillatory activity is less synchronous across heterotopic bands and mutants are less responsive to pharmacological inhibition of cholecystokinin-containing interneurons. This study will aid not only in our understanding of how cellular networks form but highlight vulnerable cellular circuit motifs that might be generalized across disease states.

Identifiants

pubmed: 32558643
doi: 10.7554/eLife.55173
pii: 55173
pmc: PMC7340499
doi:
pii:

Substances chimiques

Calbindins 0
Cholecystokinin 9011-97-6

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIGMS NIH HHS
ID : FI2 GM123992
Pays : United States

Déclaration de conflit d'intérêts

JD, TE, SG, XY, CM No competing interests declared

Références

J Comp Neurol. 1979 Jun 1;185(3):393-422
pubmed: 438366
Exp Neurol Suppl. 1965 Oct;:Suppl 2:1-70
pubmed: 5838955
J Physiol. 1998 Nov 15;513 ( Pt 1):117-26
pubmed: 9782163
Clin Genet. 2007 Oct;72(4):296-304
pubmed: 17850624
J Comp Neurol. 2011 Aug 1;519(11):2061-89
pubmed: 21491433
J Comp Neurol. 1973 Jan 15;147(2):235-54
pubmed: 4682775
Eur J Neurosci. 2003 Sep;18(5):1213-22
pubmed: 12956720
Novartis Found Symp. 2007;288:21-35; discussion 35-44, 96-8
pubmed: 18494250
Am J Med Genet A. 2017 Jun;173(6):1473-1488
pubmed: 28440899
Neuron. 2014 Jun 4;82(5):1129-44
pubmed: 24836505
Cereb Cortex. 2015 Sep;25(9):2517-28
pubmed: 24759695
Nat Neurosci. 2005 Oct;8(10):1319-28
pubmed: 16158066
Annu Rev Neurosci. 1978;1:297-326
pubmed: 386903
J Neurosci. 2010 Nov 17;30(46):15700-9
pubmed: 21084626
J Neurosci. 2011 Jul 27;31(30):10948-70
pubmed: 21795545
Nat Genet. 1998 Aug;19(4):333-9
pubmed: 9697693
Brain Struct Funct. 2011 Nov;216(4):301-17
pubmed: 21597968
Nat Neurosci. 2018 Apr;21(4):484-493
pubmed: 29593317
Nat Neurosci. 2010 Jul;13(7):822-4
pubmed: 20512133
J Chem Neuroanat. 1997 Dec;14(1):1-19
pubmed: 9498163
Cereb Cortex. 2010 Aug;20(8):1904-14
pubmed: 19955470
J Neurosci. 2000 Apr 1;20(7):2439-50
pubmed: 10729324
Nat Neurosci. 2017 Apr;20(4):559-570
pubmed: 28263300
Hippocampus. 2000;10(2):187-97
pubmed: 10791841
Science. 2005 Nov 4;310(5749):805-10
pubmed: 16272112
Nat Neurosci. 2015 Feb;18(2):170-81
pubmed: 25622573
Cereb Cortex. 2017 Oct 1;27(10):4851-4866
pubmed: 27620977
Neuron. 2005 Nov 23;48(4):591-604
pubmed: 16301176
Nat Neurosci. 2015 Sep;18(9):1281-1290
pubmed: 26214372
Nature. 1998 Jul 9;394(6689):186-9
pubmed: 9671302
Eur J Neurosci. 2000 Sep;12(9):3239-49
pubmed: 10998107
J Neurosci. 2012 Sep 12;32(37):12862-75
pubmed: 22973010
Eur J Neurosci. 2012 May;35(10):1573-85
pubmed: 22607003
Neuron. 2007 Oct 4;56(1):33-42
pubmed: 17920013
Behav Neurosci. 2003 Dec;117(6):1257-75
pubmed: 14674845
J Neurophysiol. 1993 Jul;70(1):97-116
pubmed: 8395591
Nature. 2011 Apr 21;472(7343):351-5
pubmed: 21460837
Neuron. 2018 Jul 11;99(1):98-116.e7
pubmed: 29937280
Curr Opin Neurobiol. 2018 Oct;52:107-114
pubmed: 29729527
Nat Neurosci. 2011 Apr;14(4):495-504
pubmed: 21358645
Cereb Cortex. 2016 Feb;26(2):820-37
pubmed: 26564256
J Comp Neurol. 1995 Sep 11;360(1):150-60
pubmed: 7499560
Am J Pathol. 2004 Sep;165(3):775-84
pubmed: 15331402
Front Neuroanat. 2017 Jul 12;11:54
pubmed: 28747874
Dev Med Child Neurol. 2011 May;53(5):417-21
pubmed: 21410694
Mol Cell Neurosci. 2010 Mar;43(3):261-7
pubmed: 19969086
J Physiol. 2012 Feb 15;590(4):683-94
pubmed: 22199164
J Physiol. 2007 Jan 1;578(Pt 1):233-47
pubmed: 17053036
MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):858-867
pubmed: 30091967
Cold Spring Harb Symp Quant Biol. 1990;55:491-504
pubmed: 2132833
Nat Neurosci. 2013 Nov;16(11):1598-607
pubmed: 24097043
J Neurosci. 1998 Dec 1;18(23):9910-23
pubmed: 9822747
Hum Mol Genet. 2003 Apr 1;12 Spec No 1:R89-96
pubmed: 12668601
Nat Neurosci. 2006 Jun;9(6):807-15
pubmed: 16648849
J Neurosci. 2010 Jun 9;30(23):7993-8000
pubmed: 20534847

Auteurs

James A D'Amour (JA)

Program in Developmental Neurobiology, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States.
Postdoctoral Research Associate Training Program, National Institute of General Medical Sciences, Bethesda, United States.

Tyler Ekins (T)

Program in Developmental Neurobiology, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States.
Brown University, Department of Neuroscience, Providence, United States.

Stuti Ganatra (S)

Program in Developmental Neurobiology, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States.

Xiaoqing Yuan (X)

Program in Developmental Neurobiology, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States.

Chris J McBain (CJ)

Program in Developmental Neurobiology, Eunice Kennedy-Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH